Clinical trial
Electronic Decision Support for Deprescribing in Patients on Hemodialysis: a Prospective, Controlled, Quality Improvement Study
NCT05585268 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electronic Decision Support for Deprescribing in Patients on Hemodialysis: a Prospective, Controlled, Quality Improvement Study
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 3, 2022
- Completion date
- December 1, 2022
- Enrollment
- 195 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, diabete type 2, end stage renal disease, hypertension, medication interaction, renal failure chronic